Skip to main content
. Author manuscript; available in PMC: 2018 Dec 4.
Published in final edited form as: Vaccine. 2017 Oct 16;35(48 Pt B):6712–6719. doi: 10.1016/j.vaccine.2017.10.015

Table 2.

HPV Risk Factors in Unvaccinated Study Participants with FA

Variable Variable
Levels
HPV
Seronegative
(N=23)
HPV
Seropositive
(N=16)
P
N % N %
Age (years) 0–8 9 39% 2 13% 0.06
9–14 9 39% 4 25%
15–18 2 9% 2 13%
>18 3 13% 8 50%
Birth Method Vaginal 14 61% 9 56% 1.00
C-Section 9 39% 7 44%
Mother Abnormal Pap No 14 88% 10 100% 0.51
Yes 2 13% 0 0%
Fed Breast Milk as an Infant No 9 39% 5 33% 1.00
Yes 14 61% 10 67%
History of Sexual Experience No 21 91% 8 50% 0.007
Yes 2 9% 8 50%
History of Genital Warts No 23 100% 15 94% 0.41
Yes 0 0% 1 6%
History of Common Warts No 15 94% 10 77% 0.30
Yes 1 6% 3 23%
Reported Primary Smoking No 23 100% 15 94% 0.41
Yes 0 0% 1 6%
SHS Exposure No 17 77% 8 50% 0.10
Yes 5 23% 8 50%
Alcohol Consumption No 23 100% 14 88% 0.16
Yes 0 0% 2 13%
History of Blood Transfusion No 10 43% 5 31% 0.52
Yes 13 57% 11 69%
History of HSCT No 14 61% 9 56% 1.00
Yes 9 39% 7 44%

Note: HPV seropositivity was determined by the M4ELISA. HPV seropositive participants were those positive for one or more HPV types. Age at blood draw was evaluated as both a continuous and categorical variable. Frequencies (N) and percentiles (%) were provided for all variables and differences were evaluated using Fisher’s exact tests on non-missing values. Mother abnormal pap was specific to the 3 years prior to childbirth. Mother abnormal pap, secondhand smoke (SHS) exposure, and common warts had missing values which were not included in the percentages. C-section refers to cesarean section. HSCT, hematopoietic stem cell transplant. Bold p-values indicate that significant differences were observed (p-value ≤ 0.05).